Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis  Griet Debyser, Bart Mesuere, Lieven Clement, Jens.

Slides:



Advertisements
Similar presentations
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Advertisements

J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
The prevalence of “risky behaviour” in adults with cystic fibrosis
Prevalence and impact on FEV1 decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with Cystic Fibrosis  E.
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus  Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,
K. Budding, E.A. van de Graaf, T. Hoefnagel, C.E. Hack, H.G. Otten 
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in childrenwith cystic fibrosis  Cori Daines, Donald VanDeVanter,
Zhumin Zhang, Suzanne M. Shoff, HuiChuan J. Lai 
Platelet proinflammatory activity in clinically stable patients with CF starts in early childhood  Alexander Sturm, Helge Hebestreit, Corinne Koenig,
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota  Gwen Duytschaever, Geert Huys, Maarten Bekaert, Linda.
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
J.H.K. Hull, W. Tucker, A.G. Hatrick, R.K. Knight, T.B.L. Ho 
Amoxicillin–clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings  Gwen Duytschaever, Geert Huys,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis  T.O. Hirche, H. Hirche, S. Jungblut,
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
Delayed publication of clinical trials in cystic fibrosis
Clinical outcomes in cystic fibrosis patients with Trichosporon respiratory infection  Charles R. Esther, Rongpong Plongla, Alan Kerr, Feng-Chang Lin,
Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease  Peter Witters, Kris De Boeck, Lieven Dupont, Marijke.
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Evaluation of salt supplementation in CF infants
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
Demographics of glucose metabolism in cystic fibrosis
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden  Per Kristian Knudsen, Hanne.
Tregony Simoneau, Gregory S. Sawicki, Carly E. Milliren, Henry A
Physiologic endpoints for clinical studies for cystic fibrosis
François Vermeulen, Marijke Proesmans, Mieke Boon, Kris De Boeck 
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Cytokine gene polymorphisms and severity of CF lung disease
Nasal polyposis in lung transplant recipients with cystic fibrosis
Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case–control analysis  Pieter C. Goeminne, Tim S. Nawrot,
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Michael D. Parkins, R. Andres Floto  Journal of Cystic Fibrosis 
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
A new method of sweat testing: the CF Quantum®sweat test
C. Van de Kerkhove, P. C. Goeminne, M. Kicinski, T. S. Nawrot, N
A. Sapet, A. C. Normand, M. Oudyi, N. Stremler- Le Bel, R. Piarroux, J
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in childrenwith cystic fibrosis  Cori Daines, Donald VanDeVanter,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case– control study  Maarten Verregghen, Harry G. Heijerman, Monique.
Gut dysbiosis in cystic fibrosis
CFTR modulators and pregnancy: Our work has only just begun
Beta-lactam allergy in adults with cystic fibrosis
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
Michael W. Konstan, Jeffrey S. Wagener, Donald R. VanDevanter, David J
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Absence of a gender gap in survival
Cystic fibrosis and pregnancy in the modern era: A case control study
Presentation transcript:

Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis  Griet Debyser, Bart Mesuere, Lieven Clement, Jens Van de Weygaert, Pieter Van Hecke, Gwen Duytschaever, Maarten Aerts, Peter Dawyndt, Kris De Boeck, Peter Vandamme, Bart Devreese  Journal of Cystic Fibrosis  Volume 15, Issue 2, Pages 242-250 (March 2016) DOI: 10.1016/j.jcf.2015.08.003 Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Taxonomic composition of the faecal microbiota in the patients with CF and in the unaffected siblings based on average relative spectral counts assigned to phylum (A) and genus (B). Coloured blocks indicate taxa with an average relative abundance >1% in at least the sibling or the patients. The remaining taxa were binned as ‘other’ along with the fraction of peptides that could not be assigned at the taxa level ‘unclassified’ (uncl.). Journal of Cystic Fibrosis 2016 15, 242-250DOI: (10.1016/j.jcf.2015.08.003) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Changes of the relative abundance of Enterobacteriaceae (A), Ruminococcus gnavus (B) and Faecalibacterium prausnitzii (C) in patients with cystic fibrosis. The left panels display raw ratios of spectral counts for each taxon on the total bacterial spectral counts in unaffected siblings (sib) and patients with CF (CF). The right panels visualise log transformed raw ratios (dots) along with the zero inflated negative binomial (ZINB) model fit (thick lines) for siblings in black and for patients in red. Patient–sibling pairs are connected with lines. The raw ratios indicate that Enterobacteriacea and R. gnavus typically have a higher prevalence in the faecal microbiota of CF patients compared to their corresponding siblings, while the reverse is true for F. prausnitzii. The ZINB model confirms this. The regression lines in the plot represent the average logged relative abundance for siblings (black) and patients (red) in function of age. The difference between the lines represents the effect of CF after correcting for age, which was highly significant (q=0.001 and q=0.005, respectively). Journal of Cystic Fibrosis 2016 15, 242-250DOI: (10.1016/j.jcf.2015.08.003) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions